GovChime
Notice ID: 7cdbe99d961b458e9691ab2f7a753999Award NoticeAwarded

Fexofenadine Tablets

Awarded on February 18, 2025. Full description on SAM.gov.

Awarded tounder SPE2D2-25-D-0005 (source: SAM.gov award notice)• $10.8M

Overview

Posted
January 7, 2026
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Place of performance
Hauppauge, New York, 11788
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Feb 18, 2025
Award amount (SAM.gov award notice)
$10.8M

Identifiers

Solicitation number
SPE2D2-25-D-0005
Notice ID
7cdbe99d961b458e9691ab2f7a753999
Award number (PIID)
SPE2D2-25-D-0005

Description

Fexofenadine Tablets SPE2D2-25-D-0005 Option 1

Full description on SAM.gov

Award Overview

Award Number

SPE2D2-25-D-0005

Award Amount (SAM.gov award notice)

$10.8M

Award Date

Feb 18, 2025

Awardee

Awardee UEI

C1S5SQ88KY67

Awardee CAGE Code

8PNH3

Awardee Address

Hauppauge, NY 11788, UNITED STATES

Original Solicitation

Notice ID: 7cdbe99d961b458e9691ab2f7a753999

Posted Date: Jan 7, 2026

Original Response Deadline: Not specified

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (2)

  • SF30_SPE2D225D0005P00003Signed.PDF

    25 KBAdded in Award Notice version 4Posted
    Download
  • Fexofenadine Award SPE2D2-25-D-0005 Signed.pdf

    1.3 MBAdded in Award Notice version 3Posted
    Download

Lifecycle

  1. 2
    Version 2SolicitationArchived

    Fexofenadine Tablets

    Notice e45ed7d5f8cc4f22b8dbeddde8e7469c on SAM.gov

  2. 3
    Version 3Award Notice

    Type changed from Solicitation to Award Notice

    Fexofenadine Tablets

    Notice 7f5ae7db321e46a6aece943315e8d30b on SAM.gov

  3. 4
    Version 4Award NoticeCurrent

    Fexofenadine Tablets

    Notice 7cdbe99d961b458e9691ab2f7a753999 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

SPE2D2-25-D-0005

Archive Date

Feb 17, 2030

Office Address

PHILADELPHIA, PA, 19111